NovaBridge Biosciences (NBP) EBIT (2019 - 2025)
NovaBridge Biosciences (NBP) posted quarterly EBIT of -$72.9 million for Q4 2025, down 445.21% year-on-year from $21.1 million in Q4 2024, and down 710.99% on a QoQ basis from -$9.0 million in Q3 2025.
NovaBridge Biosciences (NBP) EBIT (2019 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has reported EBIT for 5 consecutive years, with -$72.9 million the latest figure, recorded in Q4 2025.
- Quarterly EBIT fell 445.21% year-over-year to -$72.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$94.3 million (down 83.31% YoY) and the FY2025 annual result came in at -$94.3 million, down 83.31% from the prior year.
- EBIT declined to -$72.9 million in Q4 2025 per NBP's latest filing, from -$9.0 million in the prior quarter.
- Over the last five years, EBIT for NBP reached as high as -$5.3 million in Q1 2025 and fell as low as -$72.9 million in Q4 2025.
- A 3-year average of -$18.9 million and a median of -$12.0 million in 2023 frame the typical range for EBIT.
- Annual changes were most pronounced in 2024 — EBIT soared 66.12% — and 2025, when it slumped 445.21%.
- Year by year, EBIT stood at -$39.5 million in 2023, then surged by 66.12% to -$13.4 million in 2024, then sank by 445.21% to -$72.9 million in 2025.
- According to Business Quant data, EBIT over the past three periods registered -$72.9 million, -$9.0 million, and -$7.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | NovaBridge Biosciences | 389.86 Mn | 389.86 Mn | - | -72.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -72.90 Mn |
| Sep 30, 2025 | -8.99 Mn |
| Jun 30, 2025 | -7.11 Mn |
| Mar 31, 2025 | -5.27 Mn |
| Dec 31, 2024 | -13.37 Mn |
| Sep 30, 2024 | -12.41 Mn |
| Jun 30, 2024 | -17.14 Mn |
| Mar 31, 2024 | -8.50 Mn |
| Dec 31, 2023 | -39.46 Mn |
| Sep 30, 2023 | -10.63 Mn |
| Jun 30, 2023 | -12.05 Mn |
| Dec 31, 2020 | 159.19 Mn |
| Sep 30, 2020 | 88.52 Bn |
| Dec 31, 2019 | -47.37 Mn |
| Sep 30, 2019 | -43.72 Mn |